Boston Scientific Difference between equity method investment carrying value and book value increased by 16.8% to $375.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 47.1%, from $255.00M to $375.00M.
other_equity_method_investment_difference_between_carryi_e58937| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $314.00M | $289.00M | $237.00M | $233.00M | $242.00M | $209.00M | $230.00M | $236.00M | $237.00M | $233.00M | $255.00M | $374.00M | $321.00M | $375.00M |
| QoQ Change | — | -8.0% | -18.0% | -1.7% | +3.9% | -13.6% | +10.0% | +2.6% | +0.4% | -1.7% | +9.4% | +46.7% | -14.2% | +16.8% |
| YoY Change | — | — | — | -25.8% | -16.3% | -11.8% | -1.3% | -2.5% | +13.4% | +1.3% | +8.1% | +57.8% | +37.8% | +47.1% |